RxDoctor Payments DataLook up a doctor →

Marc Dean, MD

Otolaryngology · Fort Worth, TXNPI 1730381310

Payments from drug & device makers

$593,855in general payments, 2019–2025

Across 341 payments — averaging $1741.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acclarent, Inc$353K
  • Medical Device Business Services, Inc.$121K
  • Aerin Medical Inc.$52K
  • Sanofi US Services Inc.$42K
  • Stryker$13K
  • Biosense Webster, Inc.$9K
  • plus $4K from 17 others
$3,200in research payments, 2019–2025

Across 1 payment — averaging $3200.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Aerin Medical Inc.$3K

What the payments were for

  • Consulting fees$441,81591%
  • Speaking & faculty fees$7,0001%
  • Travel & lodging$30,5266%
  • Food & beverage$6,8971%
  • Gifts$40%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$593,855 in reported general payments places this provider in the 95th percentile of 729 otolaryngology providers in Texas.

See all otolaryngology providers in Texas

Medicare billing

Part B allowed, 2024
$227,373
Medicare patients
203
Services billed
734

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide319$10,086
Omeprazole509$8,481
Fluticasone Propionate295$4,880
Sumatriptan12$3,033
Budesonide19$2,413
Azelastine Hcl79$2,213
Cimetidine65$1,888
Esomeprazole Magnesium56$1,411
Mupirocin35$950
Cefdinir45$878
Pantoprazole Sodium46$832
Ondansetron OdtOndansetron81$680
Doxycycline Hyclate46$636
Montelukast Sodium51$559
Gabapentin52$446

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Fort Worth

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →